Doseme LLC

Website
2405 Holcombe Blvd
Houston, TX 77021
https://doseme-rx.com

DoseMe LLC is a leading provider of Bayesian dosing software, offering the world's first and largest Bayesian dosing platform designed for clinical practice. Their intuitive dosing platform, DoseMeRx, simplifies the implementation of Bayesian dosing, allowing healthcare professionals to spend more time on patients and less on calculations. With 24/7 support from real people, DoseMeRx ensures that customers receive the best-in-class customer service. Trusted worldwide, DoseMeRx is clinically proven to significantly improve patient outcomes and lower costs, making it the go-to choice for clinical pharmacists.

With a diverse range of drug models across various therapeutic areas, including vancomycin, infectious disease, oncology, and pediatrics, DoseMeRx offers a comprehensive solution for therapeutic drug monitoring. As the only HITRUST CSF certified Bayesian dosing platform, DoseMeRx prioritizes patient data security and integrity, providing peace of mind to healthcare providers. By standardizing workflows and optimizing therapeutic drug monitoring programs, DoseMeRx helps healthcare systems achieve continuity of care and simplify AUC compliance workflows. With numerous success stories from satisfied customers, DoseMeRx has revolutionized pharmacokinetic services and improved patient care in institutions worldwide.

Generated from the website

Own this business?
See a problem?

You might also like

Salarius Pharmaceuticals, Inc

Iterion Therapeutics is a clinical-stage biopharmaceutical company based in Houston, TX, dedicated to revolutionizing healthcare through innovative drug discovery. Their lead product, tegavivint, is a first-in-class small molecule inhibitor that targets Transducin Beta-like Protein 1 (TBL1), a key component of the Wnt beta-catenin signaling pathway implicated in various types of cancers. By binding to TBL1 and displacing beta-catenin, tegavivint inhibits oncogenic gene expression, offering a promising approach to treating cancer. Iterion Therapeutics has already demonstrated the safety, pharmacodynamic effects, and clinical activity of tegavivint in a completed Phase 1 clinical trial. They are currently enrolling patients for a company-sponsored clinical trial in hepatocellular carcinoma, a cancer type with a high prevalence of Wnt beta-catenin mutations and significant unmet clinical needs. Additionally, Iterion has established collaborative relationships with leading institutions to further investigate tegavivint's potential in complementary investigator-sponsored trials.Generated from the website
Nonresidential construction, nec, nec

Vapogenix

Vapogenix is a clinical-stage pharmaceutical company based in Houston, TX, dedicated to revolutionizing pain treatment through the development and commercialization of a patent-protected class of non-opioid topical analgesics. Their locally acting novel formulation of volatile general anesthetics offers rapid and prolonged pain relief, reducing or eliminating the need for chronic opioid use while avoiding systemic side effects. With a focus on addressing the inadequacies of current pain treatment options, Vapogenix aims to provide effective solutions for severe pain from acute injuries and chronic wounds. Their innovative approach not only alleviates pain but also mitigates the risks associated with opioid analgesics, such as addiction and dependence, ultimately improving patient outcomes.Generated from the website

Nanda, Seema OD

Nanda Dry Eye Vision Institute, led by Dr. Seema Nanda, specializes in the management and treatment of corneal conditions and dry eye disease. The institute offers a range of latest treatments and developments in ocular medicine, ensuring patients receive comprehensive care for various eye conditions such as blepharitis, cataracts, glaucoma, and keratoconus. Dr. Nanda is dedicated to educating both patients and medical professionals through published articles and webinars focused on advancements in eye care. The institute fosters a commitment to ongoing learning and treatment innovation in the field of ocular health. Generated from the website
United States›Texas›Houston›Doseme LLC

Partial Data by Infogroup (c) 2024. All rights reserved.